The Corporate Transparency Act (“CTA”) was enacted in 2021 as part of the Anti-Money Laundering Act of 2020. The CTA requires certain business entities (“Reporting Companies”) to report beneficial ownership information (“BOI”), and, for entities created or registered on or after January 1, 2024, information with respect to any individual who directly files the document
February 2024
Healthcare & Life Sciences Private Equity Deal Tracker: Gauge Invests in East Coast Institute for Research
Gauge Capital has announced it has invested in East Coast Institute for Research (ECIR).
ECIR, founded in 2007 and based in Jacksonville, Fla., is a clinical research site management organization focused primarily on the cardiovascular and metabolic therapeutic areas. The company has sites across northern Florida and Georgia.
Gauge, based in Southlake, Texas,…
Key Takeaways From McGuireWoods’ 2023 Independent Sponsor Conference
By Jeffrey D. Brooker, J.D. Costa, Jon W. Finger, Richard S. Grant and Gregory P. Hawver
McGuireWoods’ Independent Sponsor Conference in Dallas drew more than 1,500 independent sponsors and capital providers from 47 states and the District of Columbia and eight countries. Attendees gathered to network, learn and share insights.
Read on for key takeaways…
Healthcare & Life Sciences Private Equity Deal Tracker: New State Acquires Agility Recovery Services
By Trey Andrews
New State Capital Partners has announced it has acquired Agility Recovery Services.
Agility, based in Atlanta, is a provider of business continuity and disaster recovery services for healthcare organizations and customers in other sectors. Founded in 1989, Agility’s subscription-based services include access to backup power, temporary office space, network connectivity, and backup technology and equipment.…
Value-Based Care: Opportunities, Evolution and Disruptors, With Leavitt Equity Partners’ Andrew Clark
As the fee-for-service model in U.S. healthcare grows increasingly unpopular, shifting to a value-based care paradigm can move the healthcare system toward better outcomes, lower costs, better patient access and experiences — and greater investment opportunities.
In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell is joined by Andrew Clark, managing partner…
Healthcare & Life Sciences Private Equity Deal Tracker: Gemspring Sells Valant to Resurgens
Gemspring Capital has announced it has sold Valant Medical Solutions to an affiliate of Resurgens Technology Partners.
Valant, founded in 2005 and based in Seattle, is provider of SaaS-based electronic health record and practice management software for behavioral health providers.
Gemspring, based in Westport, Conn., is a middle market private equity firm that…
Healthcare & Life Sciences Private Equity Deal Tracker: Gryphon Sells Potter to KKR
Gryphon Investors has announced it has sold Potter Global Technologies to investment funds managed by KKR.
Potter, based in St. Louis, Mo., is global provider of fire safety and emergency communication products. Started in 1898, Potter serves customers in healthcare and several other markets.
Gryphon, based in San Francisco, focuses on middle market…
Illinois Supreme Court: Certain Collected Biometric Data Is Exempt From BIPA Protections
On Nov. 30, the Illinois Supreme Court, in Mosby v. The Ingalls Memorial Hospital et al., held that certain healthcare providers’ biometric data, used for healthcare operational purposes under the Health Insurance Portability and Accountability Act, is not protected under the Illinois Biometric Information Privacy Act. Read on for details about this development and why…
Growing Businesses: A Commitment to Mission and Margin, With Coltala’s Edward Crawford
Some private equity groups buy assets just to pull them apart and sell them in pieces, but that is the exception, not the norm. In fact, private equity has done a lot to build and improve businesses, especially small and medium-sized ones.
In this episode of The Corner Series, McGuireWoods partner Geoff Cockrell speaks…
FDA Warning Letter Declares Delta-8 and CBD Gummies ‘Adulterated Foods’
On Dec. 6, the U.S. Food and Drug Administration sent a warning letter to the owners of online hemp, tetrahydrocannabinol and cannabidiol retailer Hemp-xr.com for introducing adulterated foods into interstate commerce. FDA took issue with certain cookies, edibles, gummies and honey containing delta-8 THC and CBD because they “bear or contain an unsafe food additive.”…